230 related articles for article (PubMed ID: 31025490)
21. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
22. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
[TBL] [Abstract][Full Text] [Related]
23. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
24. Consensus on intratympanic drug delivery for Menière's disease.
Li S; Pyykkö I; Zhang Q; Yang J; Duan M
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3795-3799. PubMed ID: 35469039
[TBL] [Abstract][Full Text] [Related]
25. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing].
Wang XY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059
[No Abstract] [Full Text] [Related]
26. Intratympanic gentamicin treatment for Ménière's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study.
Bremer HG; van Rooy I; Pullens B; Colijn C; Stegeman I; van der Zaag-Loonen HJ; van Benthem PP; Klis SF; Grolman W; Bruintjes TD
Trials; 2014 Aug; 15():328. PubMed ID: 25135244
[TBL] [Abstract][Full Text] [Related]
27. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
28. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
Yamazaki T; Hayashi M; Komatsuzaki A
Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
[TBL] [Abstract][Full Text] [Related]
29. Update on intratympanic gentamicin for Meniere's disease.
Blakley BW
Laryngoscope; 2000 Feb; 110(2 Pt 1):236-40. PubMed ID: 10680922
[TBL] [Abstract][Full Text] [Related]
30. Systematic review of intratympanic gentamicin in Meniere's disease.
Diamond C; O'Connell DA; Hornig JD; Liu R
J Otolaryngol; 2003 Dec; 32(6):351-61. PubMed ID: 14967079
[TBL] [Abstract][Full Text] [Related]
31. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
Quaranta A; Aloisi A; De Benedittis G; Scaringi A
Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
33. Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.
Jumaily M; Faraji F; Mikulec AA
Otol Neurotol; 2017 Mar; 38(3):386-391. PubMed ID: 28192380
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
[TBL] [Abstract][Full Text] [Related]
35. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.
Ahmadzai N; Cheng W; Kilty S; Esmaeilisaraji L; Wolfe D; Bonaparte J; Schramm D; Fitzpatrick E; Lin V; Skidmore B; Hutton B
PLoS One; 2020; 15(9):e0237523. PubMed ID: 32870918
[TBL] [Abstract][Full Text] [Related]
37. Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Non-Serviceable Hearing.
Thomas L; Lepcha A; Reka K; Augustine AM; Alex A; Philip A; Mammen MD
Indian J Otolaryngol Head Neck Surg; 2022 Dec; 74(Suppl 3):3738-3745. PubMed ID: 36742746
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of intratympanic gentamicin injection to treat Ménière's disease.
Huon LK; Fang TY; Wang PC
Otol Neurotol; 2012 Jul; 33(5):706-14. PubMed ID: 22699980
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
Abou-Halawa AS; Poe DS
Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
[TBL] [Abstract][Full Text] [Related]
40. Preliminary Evidence for the Effects of Gentamicin on Vertical Semicircular Canals.
Khan S; Quimby AE; Hwa TP; Bigelow DC; Brant J; Ruckenstein MJ
ORL J Otorhinolaryngol Relat Spec; 2024; 86(2):89-94. PubMed ID: 38387448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
